Urinary podocyte-associated mRNA profile in Egyptian patients with diabetic nephropathy.
Diabetic nephropathy
Nephrin
Podocalyxin
Podocyte
Journal
Diabetes & metabolic syndrome
ISSN: 1878-0334
Titre abrégé: Diabetes Metab Syndr
Pays: Netherlands
ID NLM: 101462250
Informations de publication
Date de publication:
Historique:
received:
02
07
2019
accepted:
29
07
2019
pubmed:
20
8
2019
medline:
13
2
2020
entrez:
20
8
2019
Statut:
ppublish
Résumé
Podocyte injury and subsequent excretion in urine play a crucial role in the pathogenesis and progression of diabetic nephropathy (DN). Quantification of messenger RNA expression in urinary sediment by real-time PCR is emerging as a noninvasive method of screening DN-associated biomarkers. We aimed to study the expression of podocyte-associated genes in urinary sediment and their relation to disease severity in type 2 diabetic Egyptian patients with diabetic nephropathy. ology: Sixty patients with type 2 diabetes mellitus were recruited in addition to twenty non diabetic healthy volunteers. Relative mRNA abundance of nephrin, podocalyxin, and podocin were quantified, and correlations between target mRNAs and clinical parameters were examined. The urinary mRNA levels of all genes studied were significantly higher in diabetics compared with controls (p < 0.001), and mRNA levels increased with DN progression. Urinary mRNA levels of all target genes positively correlated with both UAE and HbA The urinary mRNA profiles of nephrin, podocalyxin, and podocin were found to increase with the progression of DN, which suggested that quantification of podocyte-associated molecules will be useful biomarkers of DN.
Identifiants
pubmed: 31425946
pii: S1871-4021(19)30461-8
doi: 10.1016/j.dsx.2019.07.048
pii:
doi:
Substances chimiques
Biomarkers
0
Glycated Hemoglobin A
0
RNA, Messenger
0
hemoglobin A1c protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2849-2854Informations de copyright
Copyright © 2019 Diabetes India. Published by Elsevier Ltd. All rights reserved.